ELAVL2/ELAVL4 Antibody

Shipped with Ice Packs
In Stock

Description

Structure and Function of ELAVL2/ELAVL4

ELAVL2 and ELAVL4 are paralogs in the ELAVL family, characterized by their RNA recognition motifs (RRMs) that bind AU-rich elements (AREs) in mRNA 3’ untranslated regions (3’UTRs). This binding stabilizes mRNA transcripts, regulating genes involved in neuronal differentiation, synaptic plasticity, and tumor suppression .

  • ELAVL2: Expressed in retinal progenitor cells, ganglion cells, and amacrine cells, with roles in maintaining retinal function and visual acuity . It regulates transcription factors critical for neuronal differentiation .

  • ELAVL4: Enriched in cortical neurons and radial glial cells, influencing neuronal migration and axonogenesis . It stabilizes proto-oncogenic transcripts like N-myc and tumor suppressors like p27 .

Neurological Studies

  • Retinal Development: ELAVL2-deficient mice exhibit reduced retinal ganglion cell activity and impaired visual acuity .

  • Neurodegeneration: Dysregulation of ELAVL2/ELAVL4 correlates with Alzheimer’s disease and autism spectrum disorder .

Cancer Research

  • Glioblastoma (GBM): ELAVL2 loss promotes mesenchymal transition and chemoresistance in GBM, while its overexpression improves survival .

  • Small Cell Lung Cancer (SCLC): ELAVL4 is a diagnostic marker, with 100% positivity in SCLC cells .

Other Applications

  • Immunohistochemistry: Detects neuronal markers in paraneoplastic encephalomyelitis .

  • Co-Immunoprecipitation: Identifies protein complexes involving ELAVL4 in neuronal progenitors .

Key Research Findings

StudyFindingsCitation
Retinal developmentELAVL2 regulates retinal ganglion cell differentiation and visual acuity
Glioblastoma progressionELAVL2 loss correlates with aggressive MES transition and poor prognosis
SCLC diagnosticsELAVL4 is expressed in 100% of SCLC cells, aiding tumor identification
Neuronal migrationELAVL4 stabilizes N-myc and p27 mRNAs, regulating neuroblastoma growth

Clinical Relevance

  • Biomarkers: Low ELAVL2 expression predicts aggressive glioma subtypes and poor survival .

  • Therapeutic Targets: Inhibitors targeting ELAVL2/ELAVL4 may enhance chemotherapy efficacy in GBM .

Product Specs

Form
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your order. Delivery times may vary depending on the shipping method and destination. For specific delivery timelines, please consult your local distributors.
Synonyms
ELAV like neuron specific RNA binding protein 2 antibody; ELAV like Neuronal Protein 1 antibody; ELAV like Protein 2 antibody; ELAV-like neuronal protein 1 antibody; ELAV-like protein 2 antibody; ELAV2_HUMAN antibody; ELAVL2 antibody; HEL-N1 antibody; HELN1 antibody; HU Antigen B antibody; Hu-antigen B antibody; HuB antibody; Nervous System Specific RNA Binding Protein MelN1 antibody; Nervous system-specific RNA-binding protein Hel-N1 antibody
Target Names
ELAVL2/ELAVL4
Uniprot No.

Target Background

Function
ELAVL2 is an RNA-binding protein that interacts with the 3' untranslated region (3'UTR) of target mRNAs. It appears to recognize a GAAA motif. ELAVL2 can bind to its own 3'UTR, as well as the 3'UTRs of FOS and ID.
Gene References Into Functions
  1. ELAVL2-regulated co-expression networks are enriched for genes involved in neurodevelopment and synaptic function. These networks also include genes exhibiting human-specific expression patterns in the frontal pole. These findings indicate that ELAVL2's regulation of transcript expression is crucial for neuronal function and may have clinical relevance to autism. (PMID: 27260404)
  2. 17 proteins that interact with at least 10 other proteins (P < 0.05, FDR < 0.05) were identified as hub proteins. (PMID: 26366417)
  3. Analysis of gene-environment interaction between 33 genes and maternal smoking revealed evidence of interaction with two additional genes: GRID2 and ELAVL2, among European mothers. (PMID: 23512105)
  4. The timing of the switch from proliferation to neuronal differentiation is controlled by the mutually antagonistic action of two RNA-binding proteins, Hu and hnRNP K, through post-transcriptional regulation of p21 mRNA. (PMID: 15671036)
  5. Elevated levels of mRNA transcripts have been observed in Small Cell Lung Cancer patients. (PMID: 18607064)

Show More

Hide All

Database Links

HGNC: 3313

OMIM: 601673

KEGG: hsa:1993

STRING: 9606.ENSP00000369460

UniGene: Hs.166109

Protein Families
RRM elav family
Tissue Specificity
Brain; neural-specific.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.